Gamma ASSR Detection for Depression Using Chirp Stimulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for depressive disorder rely on subjective symptomatology, lacking objective biomarkers, and gamma oscillations, which are crucial for diagnosis, are often disregarded due to low amplitude and physiological artifacts.

Innovation Solution

An automatic detection system utilizing a frequency-increasing chirp auditory stimulation paradigm to induce gamma Auditory Steady-State Response (ASSR), extracting features like ERSP, ITC, and WPLI from preprocessed EEG data, and applying decision fusion for comprehensive evaluation and detection of depressive disorder.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional subjective symptomatology is used for diagnosis, then the diagnostic process is simple and accessible, but the diagnosis lacks objectivity and reliability

Engineering Contradiction:
Improvediagnostic reliabilityVSAvoiddiagnostic system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces subjective clinical assessment with objective physiological measurement using auditory steady-state response (ASSR) and electroencephalogram (EEG) technology. The system uses auditory stimuli to elicit brain wave responses that can be objectively measured and analyzed to diagnose depressive disorder, substituting the mechanical/subjective clinical interview with an automated physiological detection system.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces ASSR and EEG as intermediary biomarkers between the depressive disorder and the diagnostic process. These physiological signals serve as objective mediators that reflect brain function states, providing a bridge between subjective symptoms and objective diagnosis criteria.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If gamma oscillations are used as biomarker, then objective diagnosis is enabled, but the signal is obscured by low amplitude and physiological artifacts

Engineering Contradiction:
Improvegamma oscillation detection precisionVSAvoidsignal interference
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent employs periodic auditory steady-state response (ASSR) stimulation at specific frequencies (including gamma frequency around 40 Hz) to elicit synchronized brain oscillations. This periodic stimulation enhances the signal-to-noise ratio by creating rhythmic neural responses that stand out from background brain activity and physiological artifacts.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The patent changes the stimulation parameters by using frequency-modulated auditory stimuli and analyzing brain responses at specific frequency bands (particularly gamma frequency). By adjusting stimulus frequency and analyzing spectral characteristics, the system optimizes the detection of gamma oscillations while filtering out artifacts.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If multiple feature parameters are extracted for comprehensive evaluation, then detection accuracy is improved, but processing complexity increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidsignal processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex ASSR signal into multiple feature parameters (amplitude, phase coherence, functional connectivity, spectral characteristics) that can be independently extracted and analyzed. This segmentation allows comprehensive evaluation of depressive disorder through multiple dimensions while managing processing complexity through systematic analysis of distinct features.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from single-parameter analysis to multi-dimensional feature extraction, analyzing ASSR signals across multiple dimensions including time domain, frequency domain, and spatial distribution characteristics. This dimensional expansion enables comprehensive evaluation of brain function states for accurate depression detection.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the stability and signal-to-noise ratio of gamma ASSR, enabling early identification of depressive disorders through objective and accurate detection, providing timely treatment and auxiliary support for clinical diagnosis.

Implementation Method 1

auditory steady-state response (ASSR) is a cortical oscillation entrained to both the frequency and phase of periodic auditory stimuli, generated by a whole auditory nervous system

Methodology Applied
Scientific EffectAuditory Steady-State Response:

Implementation Method 2

Cerebral cortex response signals are recorded and preprocessed by a data acquisition module

Methodology Applied
Scientific EffectElectroencephalogram:

Data Source

PatentUS20240172977A1Automatic detection system for depressive disorder based on high frequency auditory steady-state response
Publication Date: 2024.05.30 TIANJIN UNIV
  • US20240172977A1 patent drawing
  • US20240172977A1 patent drawing

AI summary

The present disclosure discloses an automatic detection system for depressive disorder based on high frequency ASSR. The system includes an auditory stimulation module, a data acquisition module, a signal processing module, a depression detection module and an output module; the auditory stimulation module presents 40 Hz frequency-increasing sound stimulation signals to a user; the data acquisition module acquires EEG signals by a non-intrusive method for preprocessing to obtain ASSR data; the signal processing module extracts depressive disorder-related EEG features from the ASSR data; the depression detection module identifies a user depression state through decision fusion of the depressive disorder-related EEG features; and the output module identifies the user depression state according to the EEG features to generate an evaluation report for abnormity in EEG response, and feeds it back to the user.